Skip to content

Vera Therapeutics VERA Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-71.3%-31.8pp-50.7%-5.9pp-73.2%-8.1pp-54.8%-8.8pp-39.5%-2.6pp
Return on assets-59.9%-25.8pp-43.1%-6.5pp-56.9%-7.5pp-44.7%-8.3pp-34.1%-4.1pp
Return on invested capital-77.1%-32.8pp-72.8%-21.3pp-73.5%-7.9pp-55.4%-7.8pp-44.3%+8.1pp
Liquidity
Current ratio13.6×-14.0×13.6×-12.0×12.2×-1.6×17×-4.4×27.7×-0.9×
Quick ratio13.6×-14.0×13.6×-12.0×12.2×-1.6×17×-4.4×27.7×-0.9×
Cash ratio2.5×0.0×6.6×+3.0×1.4×+0.3×1.5×+0.1×2.5×-2.2×
Leverage
Debt-to-equity0.2×0.0×0.1×0.0×0.2×0.0×0.2×0.0×0.1×0.0×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Interest coverage-50.7×-25.0×-41.9×-20.0×-36×-14.7×-31.6×-11.4×-25.7×-4.6×
Per Share
Book value per share$6.99-16.8%$9.41-9.8%$6.25+18.7%$7.34+22.5%$8.40+21.1%
Valuation
Market capitalization$2.87B+87.5%$3.59B+34.2%$1.85B-23.3%$1.44B-21.9%$1.53B-20.1%
Enterprise value$2.83B+85.0%$3.32B+25.7%$1.87B-23.4%$1.47B-21.6%$1.53B-19.5%
Price / book5.7×+2.9×5.9×+1.3×4.6×-3.7×3.1×-2.5×2.9×-2.6×
Free cash flow yield-10.2%0.0pp-6.7%-1.7pp-11.4%-6.4pp-13%-7.2pp-10.2%-5.0pp
Earnings yield-12.9%-1.4pp-8.3%-2.7pp-13.6%-8.0pp-15.2%-9.3pp-11.5%-6.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Vera Therapeutics's ratios come from?
Every ratio is computed from Vera Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.